BSE Live
Jan 14, 13:06Prev. Close
4078.10
Open Price
4064.70
Bid Price (Qty.)
4030.05 (10)
Offer Price (Qty.)
4034.45 (3)
NSE Live
Jan 14, 13:06Prev. Close
4077.80
Open Price
4074.00
Bid Price (Qty.)
4031.00 (1)
Offer Price (Qty.)
4031.60 (22)
| Balance Sheet of Sanofi India (in Rs. Cr.) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | |
| Total Share Capital | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | |
| Reserves and Surplus | 837.60 | 924.20 | 1,190.60 | 2,142.50 | 2,042.00 | |
| Total Reserves and Surplus | 837.60 | 924.20 | 1,190.60 | 2,142.50 | 2,042.00 | |
| Total Shareholders Funds | 860.60 | 1,015.50 | 1,275.80 | 2,225.60 | 2,119.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 3.70 | 4.90 | 6.30 | 30.20 | |
| Other Long Term Liabilities | 32.00 | 44.60 | 50.40 | 79.50 | 82.50 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 32.00 | 48.30 | 55.30 | 85.80 | 112.70 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 406.30 | 291.50 | 356.40 | 376.70 | 318.30 | |
| Other Current Liabilities | 194.40 | 225.70 | 241.50 | 242.90 | 220.00 | |
| Short Term Provisions | 118.50 | 134.10 | 142.70 | 130.00 | 148.50 | |
| Total Current Liabilities | 719.20 | 651.30 | 740.60 | 749.60 | 686.80 | |
| Total Capital And Liabilities | 1,611.80 | 1,715.10 | 2,071.70 | 3,061.00 | 2,918.50 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 311.20 | 310.00 | 305.20 | 332.80 | 356.60 | |
| Intangible Assets | 1.30 | 4.90 | 0.30 | 1.30 | 107.50 | |
| Capital Work-In-Progress | 18.10 | 13.30 | 18.80 | 8.90 | 6.30 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 330.60 | 330.80 | 329.10 | 346.90 | 474.10 | |
| Non-Current Investments | 0.00 | 2.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 457.40 | 457.90 | |
| Other Non-Current Assets | 154.30 | 136.00 | 132.30 | 118.80 | 153.20 | |
| Total Non-Current Assets | 485.00 | 468.80 | 461.40 | 923.10 | 1,085.20 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 499.80 | 663.80 | 408.00 | 392.40 | 368.00 | |
| Trade Receivables | 230.00 | 131.70 | 129.10 | 142.90 | 148.00 | |
| Cash And Cash Equivalents | 294.80 | 404.90 | 1,016.90 | 1,550.30 | 1,208.60 | |
| Short Term Loans And Advances | 1.00 | 1.90 | 2.00 | 4.50 | 5.70 | |
| OtherCurrentAssets | 101.20 | 44.00 | 54.30 | 47.80 | 103.00 | |
| Total Current Assets | 1,126.80 | 1,246.30 | 1,610.30 | 2,137.90 | 1,833.30 | |
| Total Assets | 1,611.80 | 1,715.10 | 2,071.70 | 3,061.00 | 2,918.50 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 297.10 | 288.80 | 283.40 | 267.70 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 717.67 | 403.68 | 572.30 | 602.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | 514.31 | 390.40 | 385.60 | 815.60 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | 18.38 | 18.38 | 18.38 | 18.38 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y